Lipid lowering therapies for aortic stenosis: a drug-target Mendelian randomisation study
Eur Heart J Cardiovasc Pharmacother
.
2024 Nov 28:pvae092.
doi: 10.1093/ehjcvp/pvae092.
Online ahead of print.
Authors
Jonathan L Ciofani
1
2
3
,
Daniel Han
4
,
Karan Rao
1
2
,
Dipender Gill
3
,
Benjamin Woolf
5
6
7
,
Kazem Rahimi
8
9
10
,
Usaid K Allahwala
1
2
,
Ravinay Bhindi
1
2
Affiliations
1
Sydney Medical School, The University of Sydney, Sydney, Australia.
2
Department of Cardiology, Royal North Shore Hospital, Sydney, Australia.
3
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
4
School of Mathematics and Statistics, University of New South Wales, Sydney, Australia.
5
MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
6
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
7
School of Psychological Science, University of Bristol, Bristol, UK.
8
Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK.
9
Nuffield Department of Women's and Reproductive Health, Medical Science Division, University of Oxford, Oxford, UK.
10
National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
PMID:
39611306
DOI:
10.1093/ehjcvp/pvae092
No abstract available